scholarly journals Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial

2018 ◽  
Vol 6 (6) ◽  
pp. 431-441 ◽  
Author(s):  
Patrick Schöffski ◽  
Jozef Sufliarsky ◽  
Hans Gelderblom ◽  
Jean-Yves Blay ◽  
Sandra J Strauss ◽  
...  
2014 ◽  
Vol 53 (23) ◽  
pp. 2711-2715 ◽  
Author(s):  
Naoki Watanabe ◽  
Tomoya Ishii ◽  
Takayuki Takahama ◽  
Akira Tadokoro ◽  
Nobuhiro Kanaji ◽  
...  

2020 ◽  
Vol Volume 13 ◽  
pp. 6927-6935
Author(s):  
De-Ning Ma ◽  
Xin-Yi Gao ◽  
Yi-Bo Dan ◽  
An-Ni Zhang ◽  
Wei-Jun Wang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document